Spectrum provides medication for opioid use disorder treatment, including the use of methadone, buprenorphine, and naltrexone, to justice-involved individuals in a variety of settings, including prisons, jails, and community-based treatment centers.
Following current best practice guidelines, offenders seeking medication support for opioid use disorders participate in a comprehensive diagnostic clinical assessment to determine the most appropriate service and initial course of treatment. Based on the assessment, offenders receive the medication that offers the greatest potential to be safe and effective, while meeting individual needs and preferences. Offenders currently enrolled and doing well in treatment prior to incarceration are encouraged to continue their current treatment modality.
Multi-disciplinary team meetings are held regularly to review individual progress, obtain feedback from the entire treatment team, update the treatment plan, and inform the reentry planning process. As symptoms or needs change over time, the intensity of treatment is adjusted to meet the offender’s current condition. Prior to release, Spectrum connects offenders to community-based providers to ensure continuity of services.